UBS Reiterates Buy on Tenet Healthcare (THC) After Hosting Management Meetings

Go back to UBS Reiterates Buy on Tenet Healthcare (THC) After Hosting Management Meetings

Mizuho Securities Upgrades Tenet Healthcare (THC) to Outperform

January 19, 2016 8:48 AM EST

Mizuho Securities upgraded Tenet Healthcare (NYSE: THC) from Neutral to Outperform with a price target of $30.00 as two Glenview partners join the board.

Analyst Sheryl R. Skolnick commented, "Glenview's two HC partners are joining THC's Board and the firm can also appoint... More